The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma

Autor: Ito, Yoshiro, Yamada, Daisaku, Kobayashi, Shogo, Sasaki, Kazuki, Iwagami, Yoshifumi, Tomimaru, Yoshito, Asaoka, Tadafumi, Noda, Takehiro, Takahashi, Hidenori, Shimizu, Junzo, Doki, Yuichiro, Eguchi, Hidetoshi
Zdroj: In Cancer Letters 28 July 2024 595
Databáze: ScienceDirect